surmount-1 trial tirzepatide non-diabetic weight loss for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Tirzepatide for the Maintenance of

While medications like Zepbound, Semaglutide GLP-1 , and Wegovy have demonstrated efficacy in clinical trials, its essential to remember that their effectiveness can vary among individuals

Skyrocketing sales of this class of drugs has transformed Eli Lilly into the most valuable pharmaceutical company in the world, by market cap

The consistency between one pen and the next is exceptional

But the short answer is not enough to keep you safe

In summary, we provide initial real-world evidence of reduced alcohol consumption in people with obesity taking Semaglutide or Tirzepatide medications, suggesting potential efficacy for treatment in AUD comorbid with obesity